ArticleWorld journal of clinical pediatrics2026
Circulating levels of growth differentiation factor-15 and its genetic variants -3148C>G (rs4808793) in pediatric cardiac patients.
Article in World journal of clinical pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGrowth differentiation factor-15 (GDF-15) is a stress-responsive cytokine. Though less extensively studied in children than in adults, recent evidence highlights the potential value of GDF-15 in pediatric cardiology.
aimTo assess the serum GDF-15 levels and the genetic profile of GDF-15 rs4808793 among children with cardiac diseases.
methodsThis case-control study included 100 pediatric cardiac patients and 50 healthy controls. GDF-15 rs4808793 (-3148C>G) single-nucleotide polymorphism was tested
resultsOf the 69 children with various types of congenital heart diseases (CHD), 14 patients had rheumatic heart disease, and 17 had cardiomyopathy. About 50% of patients had heart failure. Significantly higher mean serum GDF-15 among patients compared to the controls,
conclusionGDF-15 is a promising biomarker in predicting congenital heart disease and heart failure in children. The genetic variants of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.